Acrux Ltd
Company Profile
Business description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Contact
103-113 Stanley Street
West Melbourne
MelbourneVIC3003
AUST: +61 383790100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
36
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,374.00 | 82.20 | -0.97% |
CAC 40 | 7,727.93 | 42.55 | -0.55% |
DAX 40 | 23,344.54 | 257.89 | 1.12% |
Dow JONES (US) | 41,389.68 | 72.25 | 0.17% |
FTSE 100 | 8,596.35 | 99.55 | 1.17% |
HKSE | 22,504.68 | 385.27 | 1.74% |
NASDAQ | 17,928.84 | 48.89 | -0.27% |
Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
NZX 50 Index | 12,421.25 | 93.36 | 0.76% |
S&P 500 | 5,674.83 | 11.84 | -0.21% |
S&P/ASX 200 | 8,157.80 | 80.20 | -0.97% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |